Patients with both PTEN-low and non-diploid tumors had a 4.63 times increased risk of BCR compared to those with PTEN-high and diploid tumors, suggesting that these two alterations together may result in a more aggressive tumor phenotype. The gene discussed is PTEN; the disease is neoplasm.